Evolent Health ROE 2014-2025 | EVH
Current and historical return on equity (ROE) values for Evolent Health (EVH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Evolent Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.18B | $0.84B | -16.89% |
| 2025-06-30 | $-0.19B | $1.13B | -15.84% |
| 2025-03-31 | $-0.14B | $1.13B | -11.71% |
| 2024-12-31 | $-0.09B | $1.19B | -7.62% |
| 2024-09-30 | $-0.10B | $1.23B | -8.34% |
| 2024-06-30 | $-0.11B | $1.24B | -8.43% |
| 2024-03-31 | $-0.14B | $1.23B | -11.17% |
| 2023-12-31 | $-0.14B | $1.25B | -11.11% |
| 2023-09-30 | $-0.11B | $1.27B | -9.47% |
| 2023-06-30 | $-0.08B | $1.27B | -7.11% |
| 2023-03-31 | $-0.04B | $1.29B | -4.42% |
| 2022-12-31 | $-0.02B | $0.86B | -2.59% |
| 2022-09-30 | $-0.01B | $0.86B | -2.02% |
| 2022-06-30 | $-0.03B | $0.61B | -4.59% |
| 2022-03-31 | $-0.03B | $0.61B | -5.23% |
| 2021-12-31 | $-0.04B | $0.69B | -6.00% |
| 2021-09-30 | $-0.05B | $0.61B | -7.65% |
| 2021-06-30 | $-0.07B | $0.61B | -11.33% |
| 2021-03-31 | $-0.27B | $0.62B | -41.91% |
| 2020-12-31 | $-0.34B | $0.62B | -48.39% |
| 2020-09-30 | $-0.52B | $0.66B | -67.32% |
| 2020-06-30 | $-0.51B | $0.65B | -57.18% |
| 2020-03-31 | $-0.34B | $0.85B | -33.11% |
| 2019-12-31 | $-0.30B | $0.93B | -27.86% |
| 2019-09-30 | $-0.12B | $1.12B | -10.59% |
| 2019-06-30 | $-0.11B | $1.15B | -9.53% |
| 2019-03-31 | $-0.09B | $1.15B | -7.75% |
| 2018-12-31 | $-0.05B | $1.19B | -4.88% |
| 2018-09-30 | $-0.05B | $1.05B | -4.67% |
| 2018-06-30 | $-0.05B | $1.05B | -4.75% |
| 2018-03-31 | $-0.06B | $1.06B | -5.63% |
| 2017-12-31 | $-0.06B | $1.05B | -6.27% |
| 2017-09-30 | $-0.07B | $1.06B | -6.92% |
| 2017-06-30 | $-0.06B | $0.89B | -7.28% |
| 2017-03-31 | $-0.05B | $0.90B | -6.47% |
| 2016-12-31 | $-0.16B | $0.91B | -19.78% |
| 2016-09-30 | $-0.15B | $0.76B | -18.15% |
| 2016-06-30 | $-0.15B | $0.77B | -17.34% |
| 2016-03-31 | $0.22B | $0.78B | 24.47% |
| 2015-12-31 | $0.33B | $0.94B | 46.53% |
| 2015-09-30 | $0.33B | $0.94B | 69.47% |
| 2015-06-30 | $0.34B | $0.95B | 140.66% |
| 2015-03-31 | $-0.03B | $0.02B | -720.00% |
| 2014-12-31 | $-0.03B | $0.00B | 5200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.466B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.084B | 58.67 |
| Tempus AI (TEM) | United States | $12.183B | 0.00 |
| Doximity (DOCS) | United States | $9.342B | 38.47 |
| Hims & Hers Health (HIMS) | United States | $8.418B | 68.48 |
| IRhythm Technologies (IRTC) | United States | $5.504B | 0.00 |
| Hinge Health (HNGE) | United States | $3.224B | 0.00 |
| Privia Health (PRVA) | United States | $2.884B | 180.38 |
| Inspire Medical Systems (INSP) | United States | $2.509B | 41.51 |
| Heartflow (HTFL) | United States | $2.383B | 0.00 |
| 10x Genomics (TXG) | United States | $2.011B | 0.00 |
| Enovis (ENOV) | United States | $1.715B | 9.01 |
| Omnicell (OMCL) | United States | $1.576B | 32.22 |
| Azenta (AZTA) | United States | $1.364B | 59.50 |
| Phreesia (PHR) | United States | $1.304B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.900B | 0.00 |
| Claritev (CTEV) | United States | $0.715B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 108.33 |
| Butterfly Network (BFLY) | United States | $0.536B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Carlsmed (CARL) | United States | $0.349B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.05 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.239B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.172B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.160B | 0.00 |
| CareCloud (CCLD) | United States | $0.133B | 7.28 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.045B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.031B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |